Objective: The optimal timing of carotid revascularization in symptomatic patients is widely debated. Therefore, we compared outcomes of revascularization <1 month vs 1 month after the index stroke.
Methods: We selected patients with preprocedural strokes undergoing nonemergent carotid endarterectomy (CEA) and carotid stenting (CAS) in the Vascular Quality Initiative between 2012 and 2017. We evaluated the risk of in-hospital stroke and 30-day mortality for expedited (<1 month) vs delayed (1 month) revascularization using multilevel logistic regression.
Results: Of 12,520 patients with an index stroke, 10,127 (81%) underwent CEA and 2393 (19%) underwent CAS. Of CEA patients, 56% (n ¼ 5668) underwent expedited revascularization compared with 59% (n ¼ 1402) for CAS (P ¼ .02). After adjustment, expedited revascularization in CEA patients was associated with a higher odds of stroke compared with delayed revascularization (odds ratio [OR], 1.6 [95% confidence interval, 1.2-2.1]; P ¼ .002; Fig) but not mortality (OR, 1.4 [0.9-2.2]; P ¼ .1). Among CAS patients, expedited revascularization was not associated with stroke (OR, 1.3 [0.9-2.1]; P ¼ .2). However, expedited CAS was associated with dramatically higher mortality compared with delayed revascularization (OR, .5]; P < .001). Among patients with expedited revascularization, CAS patients experienced a similar stroke risk to that of CEA patients (OR,1.4 [0.9-2.2]; P ¼ .1) but a higher mortality risk (OR, 2.2 [1.4-3.5]; P ¼ .001), whereas among those undergoing delayed revascularization, CAS was associated with stroke (OR, 2.6 [1.5-4.4]; P < .001) but not with mortality (OR, 0.2 [0.03-1.6]; P ¼ .1). In addition, patients with a major index stroke experienced a stroke/death rate of 11% after expedited CAS vs 5.7% after expedited CEA (P ¼ .005).
Conclusions: Symptomatic patients undergoing expedited CEA or CAS after their index stroke experienced a higher procedural risk than those undergoing delayed revascularization. However, CAS was associated with higher procedural risk than CEA, especially among those undergoing revascularization <1 month of the index stroke. Objective: The German National Quality Assurance Registry includes the data sets of all procedures (carotid endarterectomy [CEA] and carotid artery stenting [CAS] ) performed in German hospitals. The in-hospital outcome is reported by a questionnaire and finally evaluated and monitored by a federal institution (IQTIG) with the assistance of a clinical advisory board. It was the aim of this presentation to report the outcome of CEA vs CAS.
Methods: Data were collected at discharge on a mandatory electronic basis and primarily transferred to local state agencies (n ¼ 11) for plausibility check and monitoring. The data sets were anonymously compiled and evaluated by a federal institute (IQTIG). The quality of the registry is checked on a yearly basis by random sample analysis of individual charts. The reports from 2014 to 2016 include the data sets from 96,990 patients. There were 78,436 CEA (79.0%) and 18,554 CAS (18.7%) procedures performed; 2.2% of the CEA and 8.1% of the CAS procedures were special indications, including interventions before intracranial interventional procedures or other indications. Emergency procedures were included in the registry (7.0% CEA, 13.8% CAS).
Results: There were 664 hospitals that performed CEA or CAS in 2016 (654 in 2014 . In 2016, 294 hospitals performed <20 CEAs (285 CASs) in asymptomatic patients and 358 hospitals in symptomatic cases (258 CASs), respectively. The rates of preoperative neurologic examination improved to 70.9% in 2016 for CEA (68.0% in 2014) and 83.1% for CAS (77.6% in 2014). The postoperative rates were 61.2% for CEA and 61.2% for CAS in 2016 and 57.2% for CEA and 70.1% for CAS in 2014. The results for stroke and death for asymptomatic carotid stenosis were 1.18% (2016) and 1.12% (2014) for CEA and 1.71% and 1.76%, respectively, for CAS. In the case of contralateral stenosis, the results were 1.91% and 2.64% for CEA and 1.82% and 1.4% for CAS. In symptomatic stenosis, stroke/death rates for CEA were 2.87% (2016) and 2.35% (2014). CAS resulted in stroke/death rates of 3.87% and 3.5%.
Conclusions: This is the largest available registry on extracranial carotid procedures in Europe. The relative percentage of CAS procedures has been rising (18.3% to 20.0%) in the last 3 years. Both methods resulted in acceptable results for treatment of asymptomatic stenosis on a national scale. CAS was more often used in acute stroke and in combination 
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